Dr. Toby Pillinger "Antipsychotics in the treatment of schizophrenia: Defining ‘metabolically minded’ prescribing"

The metabolic side effects of some antipsychotics are well recognized and contribute to increased rates of metabolic syndrome and cardiovascular disease in this patient group. This issue has recently been published in Lancet Psychiatry comparing the metabolic side effects of 18 different antipsychotics, including predictors of antipsychotic-medicated metabolic dysregulation and the relationship between metabolic-change and symptom-change.

Du forlader nu Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
Informationerne på denne side er udelukkende forbeholdt sundhedspersoner
Congress
Register for access to Progress in Mind in your country